Anticoagulation in the ICU: a future for contact pathway inhibition?

Intensive Care Med. 2023 Nov;49(11):1388-1391. doi: 10.1007/s00134-023-07172-y. Epub 2023 Jul 31.

Charlotte J Van Edom^{1

2}, Diana A Gorog^{3

4}, Christophe Vandenbriele^{5

6

7}

¹ Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
² Department of Cardiovascular Diseases, University Hospitals of Leuven, Herestraat 49, 3000, Leuven, Belgium.
³ Faculty of Medicine, National Heart and Lung Institute, Imperial College, London, UK.
⁴ Postgraduate Medical School, University of Hertfordshire, Hertfordshire, UK.
⁵ Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. Christophe.vandenbriele@uzleuven.be.
⁶ Department of Cardiovascular Diseases, University Hospitals of Leuven, Herestraat 49, 3000, Leuven, Belgium. Christophe.vandenbriele@uzleuven.be.
⁷ Department of Critical Care, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK. Christophe.vandenbriele@uzleuven.be.

No abstract available

MeSH terms